Cargando…
Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats
This study aimed to investigate the potential of an oral formulation (QV formulation) containing Quercetin and a Dipeptidyl Peptidase-4 Inhibitor (DPP-4 inhibitor), Vildagliptin, in improving metabolic homeostasis in type 1 diabetes model. Female albino Fischer rats were divided into four groups: un...
Autores principales: | Miranda, Pedro Henrique de A., Lacerda, Kissyla Christine Duarte, Araújo, Carolina Morais, Barichello, José Mario, Lima, Wanderson Geraldo, Costa, Daniela Caldeira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192983/ https://www.ncbi.nlm.nih.gov/pubmed/30333575 http://dx.doi.org/10.1038/s41598-018-33727-x |
Ejemplares similares
-
The Human Microbial Metabolism of Quercetin in Different Formulations: An In Vitro Evaluation
por: Di Pede, Giuseppe, et al.
Publicado: (2020) -
Application of Citrus and Apple Fibers for Formulation of Quercetin/Fiber Aggregates: Impact of Quercetin Concentration
por: Buljeta, Ivana, et al.
Publicado: (2022) -
Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes
por: Deacon, Carolyn F.
Publicado: (2019) -
Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress
por: Fadzeyeva, Evgenia, et al.
Publicado: (2023) -
A Micellar Formulation of Quercetin Prevents Cisplatin Nephrotoxicity
por: Casanova, Alfredo G., et al.
Publicado: (2021)